Branch Retinal Vein Occlusion as a Clinical Manifestation of Sickle Cell Trait: A Case Report.
DOI:
https://doi.org/10.51168/khs6vf72Keywords:
Branch Retinal Vein Occlusion, Clinical Manifestation, Sickle CellAbstract
Background
Sickle hemoglobin disorders are associated with vaso-occlusive and hyperviscosity-related complications involving multiple organ systems, including the eye. Ocular manifestations usually include non-proliferative or proliferative sickle retinopathy, whereas retinal vein occlusion is less commonly emphasized, particularly in individuals with sickle cell trait. This case highlights branch retinal vein occlusion as a clinically significant ophthalmic manifestation associated with sickle cell trait.
Case presentation
A 41-year-old man from Araku Valley presented with sudden blurring of vision in the right eye for 10 days, associated with decreased vision and recurrent headache. Ocular examination showed a positive comma sign in the inferior bulbar conjunctiva of both eyes. Fundus examination of the right eye revealed diffuse superficial hemorrhages with sclerotic arterioles in the superotemporal quadrant and associated macular edema, leading to a diagnosis of superotemporal branch retinal vein occlusion. Hematological evaluation showed mild anemia with microcytic indices, fragmented red blood cells, and a positive sickling test after 24 hours. High-performance liquid chromatography showed a heterozygous sickle hemoglobin pattern, with HbS at 23.8%, consistent with sickle cell trait. Extensive systemic evaluation for alternative causes of retinal vein occlusion, including thrombophilia, autoimmune, and vasculitic profiles, was negative. The patient was treated with three intravitreal ranibizumab injections and laser photocoagulation for ischemic retina, following which macular edema resolved and visual acuity stabilized at 6/9.
Conclusions
Branch retinal vein occlusion can occur as an important ocular manifestation of sickle cell trait after exclusion of other etiologies. Early ophthalmic recognition, hematological confirmation, and timely intervention are crucial for visual recovery and prevention of recurrent retinal vascular events in susceptible individuals.
References
1. Rao P, Raj EA, Natesan S, Gudi N. Prevalence of Sickle cell disease, Sickle cell trait and HBS-beta-thalassemia in India: A systematic review and Meta-analysis. Clinical Epidemiology and Global Health [Internet]. 2024 Jul 1;28:101678. Available from: https://www.sciencedirect.com/science/article/pii/S221339842400174X https://doi.org/10.1016/j.cegh.2024.101678
2. Means RT, editor. Wintrobe’s clinical hematology. Fifteenth edition. Philadelphia: Wolters Kluwer; 2024. 2980–3059 p.
3. Cotran RS, Robbins SL. Robbins & Cotran's Pathologic Basis of Disease. Tenth edition. Kumar V, Abbas AK, Aster JC, editors. Philadelphia, Pa.: Elsevier; 2021. 641–644 p.
4. Sambhara D. EyeWiki. 2025. Sickle Cell Retinopathy. Available from: https://eyewiki.org/Sickle_Cell_Retinopathy
5. Abdelaziz M, Tripathy K, Hsu J, Bhagat N, Lim JI, Marcet MM. EyeWiki. Branch retinal vein occlusion. Available from: https://eyewiki.org/Branch_Retinal_Vein_Occlusion
6. American academy of ophthalmology. Basic and clinical science course complete print set 2023, 2024. Nielsen bookdata, 2023. Retina and vitreous 12. 167-174 p.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr. Josephine Bindu Prathipaty, Dr. Jyothsna Duvvada, Dr. Dharma Raju Bennabhaktula, Dr. Bhagyalakshmi Atla (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
